| 1 |
GSM102682 |
NS1 |
54,675 |
University of Pittsburgh |
2006-03-31 |
[GeneChip] [HG-U133_Plus_2] Affymetrix Human Genome U133 Plus 2.0 Array (GPL570) |
RNA |
Homo sapiens
 |
skin |
normal skin |
| 2 |
GSM102683 |
NS2 |
54,675 |
University of Pittsburgh |
2006-03-31 |
[GeneChip] [HG-U133_Plus_2] Affymetrix Human Genome U133 Plus 2.0 Array (GPL570) |
RNA |
Homo sapiens
 |
skin |
normal skin |
| 3 |
GSM102684 |
BN1 |
54,675 |
University of Pittsburgh |
2006-03-31 |
[GeneChip] [HG-U133_Plus_2] Affymetrix Human Genome U133 Plus 2.0 Array (GPL570) |
RNA |
Homo sapiens
 |
unclassified |
source_name:benign nevi title:BN1 description:Intradermal nevus |
| 4 |
GSM102685 |
BN2 |
54,675 |
University of Pittsburgh |
2006-03-31 |
[GeneChip] [HG-U133_Plus_2] Affymetrix Human Genome U133 Plus 2.0 Array (GPL570) |
RNA |
Homo sapiens
 |
unclassified |
source_name:benign nevi title:BN2 description:Intradermal nevus |
| 5 |
GSM102686 |
AN1 |
54,675 |
University of Pittsburgh |
2006-03-31 |
[GeneChip] [HG-U133_Plus_2] Affymetrix Human Genome U133 Plus 2.0 Array (GPL570) |
RNA |
Homo sapiens
 |
unclassified |
source_name:atypical nevi title:AN1 description:Compound nevus with mild to moderate atypia |
| 6 |
GSM102687 |
AN2 |
54,675 |
University of Pittsburgh |
2006-03-31 |
[GeneChip] [HG-U133_Plus_2] Affymetrix Human Genome U133 Plus 2.0 Array (GPL570) |
RNA |
Homo sapiens
 |
unclassified |
source_name:atypical nevi title:AN2 description:Compound nevus with moderate atypia |
| 7 |
GSM102688 |
in situ 1 |
54,675 |
University of Pittsburgh |
2006-03-31 |
[GeneChip] [HG-U133_Plus_2] Affymetrix Human Genome U133 Plus 2.0 Array (GPL570) |
RNA |
Homo sapiens
 |
skin |
melanoma in situ |
| 8 |
GSM102689 |
in situ 2 |
54,675 |
University of Pittsburgh |
2006-03-31 |
[GeneChip] [HG-U133_Plus_2] Affymetrix Human Genome U133 Plus 2.0 Array (GPL570) |
RNA |
Homo sapiens
 |
skin |
melanoma in situ |
| 9 |
GSM102691 |
VGP1 |
54,675 |
University of Pittsburgh |
2006-03-31 |
[GeneChip] [HG-U133_Plus_2] Affymetrix Human Genome U133 Plus 2.0 Array (GPL570) |
RNA |
Homo sapiens
 |
skin |
VGP melanoma |
| 10 |
GSM102692 |
VGP2 |
54,675 |
University of Pittsburgh |
2006-03-31 |
[GeneChip] [HG-U133_Plus_2] Affymetrix Human Genome U133 Plus 2.0 Array (GPL570) |
RNA |
Homo sapiens
 |
skin |
VGP melanoma |
| 11 |
GSM102695 |
MGP1 |
54,675 |
University of Pittsburgh |
2006-03-31 |
[GeneChip] [HG-U133_Plus_2] Affymetrix Human Genome U133 Plus 2.0 Array (GPL570) |
RNA |
Homo sapiens
 |
skin |
MGP melanoma |
| 12 |
GSM102696 |
MGP2 |
54,675 |
University of Pittsburgh |
2006-03-31 |
[GeneChip] [HG-U133_Plus_2] Affymetrix Human Genome U133 Plus 2.0 Array (GPL570) |
RNA |
Homo sapiens
 |
skin |
MGP melanoma |
| 13 |
GSM102697 |
LN1 |
54,675 |
University of Pittsburgh |
2006-03-31 |
[GeneChip] [HG-U133_Plus_2] Affymetrix Human Genome U133 Plus 2.0 Array (GPL570) |
RNA |
Homo sapiens
 |
lymphnode |
lymph node metastasis |
| 14 |
GSM102698 |
LN2 |
54,675 |
University of Pittsburgh |
2006-03-31 |
[GeneChip] [HG-U133_Plus_2] Affymetrix Human Genome U133 Plus 2.0 Array (GPL570) |
RNA |
Homo sapiens
 |
lymphnode |
lymph node metastasis |
| 15 |
GSM102699 |
LN3 |
54,675 |
University of Pittsburgh |
2006-03-31 |
[GeneChip] [HG-U133_Plus_2] Affymetrix Human Genome U133 Plus 2.0 Array (GPL570) |
RNA |
Homo sapiens
 |
lymphnode |
lymph node metastasis |
| 16 |
GSM102700 |
cultured MGP melanoma cells |
54,675 |
University of Pittsburgh |
2006-03-31 |
[GeneChip] [HG-U133_Plus_2] Affymetrix Human Genome U133 Plus 2.0 Array (GPL570) |
RNA |
Homo sapiens
 |
skin |
metastatic melanoma culture |
| 17 |
GSM102701 |
Mel |
54,675 |
University of Pittsburgh |
2006-03-31 |
[GeneChip] [HG-U133_Plus_2] Affymetrix Human Genome U133 Plus 2.0 Array (GPL570) |
RNA |
Homo sapiens
 |
skin |
short term cultures of epidermal melanocytes |
| 18 |
GSM102702 |
Ker |
54,675 |
University of Pittsburgh |
2006-03-31 |
[GeneChip] [HG-U133_Plus_2] Affymetrix Human Genome U133 Plus 2.0 Array (GPL570) |
RNA |
Homo sapiens
 |
skin |
short term cultures of epidermal keratinocytes |
| 19 |
GSM102703 |
B RA 2 |
54,675 |
Université catholique de Louvain |
2006-03-31 |
[GeneChip] [HG-U133_Plus_2] Affymetrix Human Genome U133 Plus 2.0 Array (GPL570) |
RNA |
Homo sapiens
 |
unclassified |
source_name:Rheumatoid arthritis patient title:B RA 2 description:Labeling of RNA (cRNA synthesis) was performed according to a standard Affymetrix® procedure (One-Cycle Target Labeling kit, Affymetrix UK Ltd, High Wycombe, United Kingdom); briefly total RNA was first reverse transcribed into single-stranded cDNA using a T7-Oligo(dT) Promoter Primer and Superscript II reverse transcriptase. Next, Rnase H was added together with E. Coli DNA polymerase I and E. Coli DNA ligase, followed by a short incubation with T4 DNA polymerase in order to achieve synthesis of the second-strand cDNA. The double-stranded cDNA was purified and served as a template for the overnight in vitro transcription reaction, carried out in the presence of T7 RNA polymerase and a biotinylated nucleotide analog/ribonucleotide mix. At the end of this procedure, the biotinylated complementary RNA (cRNA) was cleaned, and fragmented by a 35 minute incubation at 95°c. Because a minimal amount of 1 ug total RNA is required for the synthesis of cRNA, not all the CD20 cell samples could be processed, accounting for the lower number of CD20 cell hybridizations. |
| 20 |
GSM102704 |
B RA 3 |
54,675 |
Université catholique de Louvain |
2006-03-31 |
[GeneChip] [HG-U133_Plus_2] Affymetrix Human Genome U133 Plus 2.0 Array (GPL570) |
RNA |
Homo sapiens
 |
unclassified |
source_name:Rheumatoid arthritis patient title:B RA 3 description:Labeling of RNA (cRNA synthesis) was performed according to a standard Affymetrix® procedure (One-Cycle Target Labeling kit, Affymetrix UK Ltd, High Wycombe, United Kingdom); briefly total RNA was first reverse transcribed into single-stranded cDNA using a T7-Oligo(dT) Promoter Primer and Superscript II reverse transcriptase. Next, Rnase H was added together with E. Coli DNA polymerase I and E. Coli DNA ligase, followed by a short incubation with T4 DNA polymerase in order to achieve synthesis of the second-strand cDNA. The double-stranded cDNA was purified and served as a template for the overnight in vitro transcription reaction, carried out in the presence of T7 RNA polymerase and a biotinylated nucleotide analog/ribonucleotide mix. At the end of this procedure, the biotinylated complementary RNA (cRNA) was cleaned, and fragmented by a 35 minute incubation at 95°c. Because a minimal amount of 1 ug total RNA is required for the synthesis of cRNA, not all the CD20 cell samples could be processed, accounting for the lower number of CD20 cell hybridizations. |